A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Summary
Third Opinion Trial Synopsis:
This study will look at how safe and well-tolerated a drug called teclistamab is when given in different combinations with other medications. The goal is to find the best dose and combination of teclistamab to use.
This study will look at how safe and well-tolerated a drug called teclistamab is when given in different combinations with other medications. The goal is to find the best dose and combination of teclistamab to use.
*Third Opinion AI Generated Synopsis
Trial Summary
The purpose of this study is to characterize the safety and tolerability of teclistamab when administered in different combination regimen and to identify the optimal dose(s) of teclistamab combination regimens.
The purpose of this study is to characterize the safety and tolerability of teclistamab when administered in different combination regimen and to identify the optimal dose(s) of teclistamab combination regimens.
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.